KEGG   PATHWAY: epz05031
Entry
epz05031                    Pathway                                
Name
Amphetamine addiction - Equus przewalskii (Przewalski's horse)
Description
Amphetamine is a psychostimulant drug that exerts persistent addictive effects. Most addictive drugs increase extracellular concentrations of dopamine (DA) in nucleus accumbens (NAc) and medial prefrontal cortex (mPFC), projection areas of mesocorticolimbic DA neurons and key components of the "brain reward circuit". Amphetamine achieves this elevation in extracellular levels of DA by promoting efflux from synaptic terminals. Acute administration of amphetamine induces phosphorylation of cAMP response element-binding protein (CREB) and expression of a number of immediate early genes (IEGs), such as c-fos. The IEGs is likely to initiate downstream molecular events, which may have important roles in the induction and maintenance of addictive states. Chronic exposure to amphetamine induces a unique transcription factor delta FosB, which plays an essential role in long-term adaptive changes in the brain.
Class
Human Diseases; Substance dependence
Pathway map
epz05031  Amphetamine addiction
epz05031

Other DBs
GO: 0001975
Organism
Equus przewalskii (Przewalski's horse) [GN:epz]
Gene
103563419  DDC; dopa decarboxylase [KO:K01593] [EC:4.1.1.28 4.1.1.105]
103558736  aromatic-L-amino-acid decarboxylase-like [KO:K01593] [EC:4.1.1.28 4.1.1.105]
103554413  SLC18A2; solute carrier family 18 member A2 [KO:K08155]
103561143  SLC18A1; solute carrier family 18 member A1 [KO:K08155]
103540167  MAOA; monoamine oxidase A [KO:K00274] [EC:1.4.3.4]
103565966  MAOB; monoamine oxidase B [KO:K00274] [EC:1.4.3.4]
103567498  SLC6A3; solute carrier family 6 member 3 [KO:K05036]
103560754  voltage-dependent L-type calcium channel subunit alpha-1D [KO:K04851]
103563588  GRIN1; glutamate ionotropic receptor NMDA type subunit 1 [KO:K05208]
103555146  GRIN2A; glutamate ionotropic receptor NMDA type subunit 2A [KO:K05209]
103549904  GRIN2B; glutamate ionotropic receptor NMDA type subunit 2B [KO:K05210]
103546604  GRIN2C; glutamate ionotropic receptor NMDA type subunit 2C [KO:K05211]
103541380  GRIN2D; glutamate ionotropic receptor NMDA type subunit 2D [KO:K05212]
103552461  GRIN3A; glutamate ionotropic receptor NMDA type subunit 3A [KO:K05213]
103549680  GRIA1; glutamate ionotropic receptor AMPA type subunit 1 [KO:K05197]
103547313  GRIA2; glutamate ionotropic receptor AMPA type subunit 2 [KO:K05198]
103557390  GRIA3; glutamate ionotropic receptor AMPA type subunit 3 [KO:K05199]
103540802  GRIA4; glutamate ionotropic receptor AMPA type subunit 4 [KO:K05200]
103565152  DRD1; dopamine receptor D1 [KO:K04144]
103558165  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]
103556196  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]
103563079  STX1A; syntaxin 1A [KO:K04560]
103549465  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]
103549616  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]
103549121  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]
103554952  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]
103548885  CALML5; calmodulin like 5 [KO:K02183]
103548886  CALML3; calmodulin like 3 [KO:K02183]
103549905  CALM1; calmodulin 1 [KO:K02183]
103558105  CALM2; calmodulin 2 [KO:K02183]
103564053  calmodulin-like protein 4 [KO:K02183]
103544963  calmodulin-alpha-like [KO:K02183]
103567415  CALML6; calmodulin like 6 [KO:K02183]
103550069  CAMK4; calcium/calmodulin dependent protein kinase IV [KO:K05869] [EC:2.7.11.17]
103565402  guanine nucleotide-binding protein G(s) subunit alpha [KO:K04632]
103547036  neuroendocrine secretory protein 55 [KO:K04632]
103563830  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]
103557289  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]
103565953  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]
103550158  PPP1R1B; protein phosphatase 1 regulatory inhibitor subunit 1B [KO:K15494]
103560150  PPP1CA; protein phosphatase 1 catalytic subunit alpha [KO:K06269] [EC:3.1.3.16]
103541647  PPP1CC; protein phosphatase 1 catalytic subunit gamma [KO:K06269] [EC:3.1.3.16]
103549472  PPP1CB; protein phosphatase 1 catalytic subunit beta [KO:K06269] [EC:3.1.3.16]
103548908  CREB1; cAMP responsive element binding protein 1 [KO:K05870]
103553756  ATF2; activating transcription factor 2 [KO:K04450]
103565289  ATF4; activating transcription factor 4 [KO:K04374]
103566499  CREB3L1; cAMP responsive element binding protein 3 like 1 [KO:K09048]
103560297  CREB3; cAMP responsive element binding protein 3 [KO:K09048]
103564266  CREB3L2; cAMP responsive element binding protein 3 like 2 [KO:K09048]
103555399  CREB3L4; cAMP responsive element binding protein 3 like 4 [KO:K09048]
103549839  CREB5; cAMP responsive element binding protein 5 [KO:K09047]
103563297  ATF6B; activating transcription factor 6 beta [KO:K09049]
103559768  PDYN; prodynorphin [KO:K15840]
103544446  ARC; activity regulated cytoskeleton associated protein [KO:K15867]
103546119  activity-regulated cytoskeleton-associated protein-like [KO:K15867]
103548618  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]
103549452  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]
103552390  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]
103552773  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]
103548960  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]
103552460  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]
103567008  FOSB; FosB proto-oncogene, AP-1 transcription factor subunit [KO:K09029]
103562180  SIRT1; sirtuin 1 [KO:K11411] [EC:2.3.1.286]
103552097  HDAC1; histone deacetylase 1 [KO:K06067] [EC:3.5.1.98]
103561341  HDAC2; histone deacetylase 2 [KO:K06067] [EC:3.5.1.98]
Compound
C00025  L-Glutamate
C00027  Hydrogen peroxide
C00076  Calcium cation
C00082  L-Tyrosine
C00355  3,4-Dihydroxy-L-phenylalanine
C00575  3',5'-Cyclic AMP
C01161  3,4-Dihydroxyphenylacetate
C01330  Sodium cation
C03758  Dopamine
D07445  Amfetamine (INN)
Reference
  Authors
Rajadhyaksha AM, Kosofsky BE
  Title
Psychostimulants, Protein phosphorylation and Gene expression: a growing role of L-type calcium channels.
  Journal
Cellscience 2:127-144 (2005)
DOI:10.1901/jaba.2005.2-127
Reference
  Authors
Cunha-Oliveira T, Rego AC, Oliveira CR
  Title
Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs.
  Journal
Brain Res Rev 58:192-208 (2008)
DOI:10.1016/j.brainresrev.2008.03.002
Reference
  Authors
Hyman SE, Malenka RC, Nestler EJ
  Title
Neural mechanisms of addiction: the role of reward-related learning and memory.
  Journal
Annu Rev Neurosci 29:565-98 (2006)
DOI:10.1146/annurev.neuro.29.051605.113009
Reference
  Authors
Rajadhyaksha AM, Kosofsky BE
  Title
Psychostimulants, L-type calcium channels, kinases, and phosphatases.
  Journal
Neuroscientist 11:494-502 (2005)
DOI:10.1177/1073858405278236
Reference
  Authors
Dudman JT, Eaton ME, Rajadhyaksha A, Macias W, Taher M, Barczak A, Kameyama K, Huganir R, Konradi C
  Title
Dopamine D1 receptors mediate CREB phosphorylation via phosphorylation of the NMDA receptor at Ser897-NR1.
  Journal
J Neurochem 87:922-34 (2003)
DOI:10.1046/j.1471-4159.2003.02067.x
Reference
  Authors
Rajadhyaksha A, Barczak A, Macias W, Leveque JC, Lewis SE, Konradi C
  Title
L-Type Ca(2+) channels are essential for glutamate-mediated CREB phosphorylation and c-fos gene expression in striatal neurons.
  Journal
J Neurosci 19:6348-59 (1999)
DOI:10.1523/JNEUROSCI.19-15-06348.1999
Reference
PMID:8753884
  Authors
Konradi C, Leveque JC, Hyman SE
  Title
Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium.
  Journal
J Neurosci 16:4231-9 (1996)
DOI:10.1523/JNEUROSCI.16-13-04231.1996
Reference
  Authors
Berke JD, Hyman SE
  Title
Addiction, dopamine, and the molecular mechanisms of memory.
  Journal
Neuron 25:515-32 (2000)
DOI:10.1016/S0896-6273(00)81056-9
Reference
  Authors
McClung CA, Nestler EJ
  Title
Neuroplasticity mediated by altered gene expression.
  Journal
Neuropsychopharmacology 33:3-17 (2008)
DOI:10.1038/sj.npp.1301544
Reference
  Authors
Chao J, Nestler EJ
  Title
Molecular neurobiology of drug addiction.
  Journal
Annu Rev Med 55:113-32 (2004)
DOI:10.1146/annurev.med.55.091902.103730
Reference
  Authors
Robertson SD, Matthies HJ, Galli A
  Title
A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters.
  Journal
Mol Neurobiol 39:73-80 (2009)
DOI:10.1007/s12035-009-8053-4
Reference
  Authors
Binda F, Dipace C, Bowton E, Robertson SD, Lute BJ, Fog JU, Zhang M, Sen N, Colbran RJ, Gnegy ME, Gether U, Javitch JA, Erreger K, Galli A
  Title
Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux.
  Journal
Mol Pharmacol 74:1101-8 (2008)
DOI:10.1124/mol.108.048447
Reference
  Authors
Sulzer D
  Title
How addictive drugs disrupt presynaptic dopamine neurotransmission.
  Journal
Neuron 69:628-49 (2011)
DOI:10.1016/j.neuron.2011.02.010
Reference
PMID:8630246
  Authors
Hyman SE
  Title
Addiction to cocaine and amphetamine.
  Journal
Neuron 16:901-4 (1996)
DOI:10.1016/S0896-6273(00)80111-7
Reference
  Authors
Renthal W, Carle TL, Maze I, Covington HE 3rd, Truong HT, Alibhai I, Kumar A, Montgomery RL, Olson EN, Nestler EJ
  Title
Delta FosB mediates epigenetic desensitization of the c-fos gene after chronic amphetamine exposure.
  Journal
J Neurosci 28:7344-9 (2008)
DOI:10.1523/JNEUROSCI.1043-08.2008
Reference
  Authors
Robison AJ, Nestler EJ
  Title
Transcriptional and epigenetic mechanisms of addiction.
  Journal
Nat Rev Neurosci 12:623-37 (2011)
DOI:10.1038/nrn3111
Reference
  Authors
Snyder GL, Galdi S, Fienberg AA, Allen P, Nairn AC, Greengard P
  Title
Regulation of AMPA receptor dephosphorylation by glutamate receptor agonists.
  Journal
Neuropharmacology 45:703-13 (2003)
DOI:10.1016/S0028-3908(03)00319-8
Reference
  Authors
Banerjee PS, Aston J, Khundakar AA, Zetterstrom TS
  Title
Differential regulation of psychostimulant-induced gene expression of brain derived neurotrophic factor and the immediate-early gene Arc in the juvenile and adult brain.
  Journal
Eur J Neurosci 29:465-76 (2009)
DOI:10.1111/j.1460-9568.2008.06601.x
Related
pathway
epz04728  Dopaminergic synapse
KO pathway
ko05031   
LinkDB

DBGET integrated database retrieval system